|
A report was received on 28 oct 2025 from the health care professional (hcp) of a 46 year old female patient with a medical history including end stage renal disease, who stated the patient experienced hypotension (~70/40 mmhg), shortness of breath, a decrease in oxygen saturation (88%), itching and a rash at the beginning of an in-center hemodialysis treatment on (b)(6) 2025.Treatment was stopped and the patient was administered a saline flush, oxygen, intravenous (iv) antihistamine, and corticosteroid (specific doses and names not provided).Additional information was received on 03 nov 2025 from the hcp who stated the patient also received an unspecified dose of iv epinephrine, recovered without sequelae, and has resumed hemodialysis with the use of a dialyzer from a different manufacturer.
|